BriaCell Therapeutics Corp. — Form D

BriaCell Therapeutics Corp. of WEST VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-12. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Saeid BabeiDirectorWest Vancouver, A1
Isaac A MareskyDirectorWest Vancouver, A1
Rahoul A SharanDirectorWest Vancouver, A1
Rahoul A SharanExecutive OfficerWest Vancouver, A1
Charles WisemanExecutive OfficerWest Vancouver, A1
Vaughn Embro-PantalonyDirectorMississauga, A6
Gadi LevinExecutive OfficerMa'anit, L3
Martin SchmiegDirectorWest Vancouver, A1
William WilliamsDirectorWest Vancouver, A1
William WilliamsExecutive OfficerWest Vancouver, A1
Jamieson BondarenkoDirectorWest Vancouver, A1
Jamieson BondarenkoExecutive OfficerWest Vancouver, A1
Rebecca TaubDirectorWest Vancouver, A1
William V WilliamsDirectorAtlanta, GA
William V WilliamsExecutive OfficerAtlanta, GA
Rahoul V SharanDirectorWest Vancouver, A1
Charles WisemanDirectorWest Vancouver, A1
Martin V SchmiegDirectorWest Vancouver, A1
Gadi V LevinExecutive OfficerWest Vancouver, A1
Saeid BabaeiDirectorWest Vancouver, A1
Chris G HealeyDirectorWest Vancouver, A1
Matthew G WrightExecutive OfficerWest Vancouver, A1
Jevin WerbesDirectorWest Vancouver, A1
Jevin WerbesExecutive OfficerWest Vancouver, A1
Rahoul SharanDirectorWest Vancouver, A1

Other filings by this issuer (3)

FiledFormOfferingSold
2021-06-15D$27.2M$27.2M
2018-04-10D$800K$800K
2014-06-20D$881K$299K

More